Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 20 announcements

Share price: ₹2.59
Market cap: ₹19.62 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -12.2×Sector 54.5×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Financial Results 4 Management Change 3 Board Meeting Date 3 Fund Raise 1 Debt & Borrowing 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Apr 2026 18:06 IST BSE

Debt & Borrowing

Transgene Biotek Debt & Borrowing

Transgene Biotek Ltd (BSE: 526139) submitted its initial disclosure confirming it does not meet SEBI's 'Large Corporate' criteria for the 2026 financial year. The company reported zero outstanding borrowings as of March 31, 2026. This filing is a routine regulatory compliance matter for listed entities regarding bond market borrowing mandates.

Open announcement → Read the filing ↗